Cutaneous Manifestations of Internal Malignancy

Current Problems in Surgery

Volumn 47, Issue 5, 2010, Pages 384-445

  Ehst, Benjamin D ^a   Minzer Conzetti, Karen ^a   Swerdlin, Amy ^a   Devere, Theresa Schroeder ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; AZATHIOPRINE; CETIRIZINE; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; DAPSONE; EMOLLIENT AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; INDOMETACIN; INTERLEUKIN 8; KERATOLYTIC AGENT; LEUKOCYTE ANTIGEN; MELPHALAN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OCTREOTIDE; POTASSIUM IODIDE; RETINOID; RETINOL; RITUXIMAB; SALICYLIC ACID; STEROID; TETRACYCLINE DERIVATIVE; TRANSFORMING GROWTH FACTOR ALPHA; UNINDEXED DRUG; UREA;

ACANTHOSIS PALMARIS; ACQUIRED HYPERTRICHOSIS LANUGINOSA; ACQUIRED ICHTHYOSIS; ACQUIRED LCHTHYOSIS; ACUTE FEBRILE NEUTROPHILIC DERMATOSIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BAZEX SYNDROME; BIRT HOGG DUBE SYNDROME; BREAST CARCINOMA; BREAST EXAMINATION; CANCER INVASION; CARCINOGENESIS; CARCINOID SYNDROME; COLON RESECTION; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; COWDEN SYNDROME; CREAM; CRYOTHERAPY; CURETTAGE; DEBRIDEMENT; DERMATOMYOSITIS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG TARGETING; ERYTHEMA GYRATUM REPENS; ERYTHRODERMA; EXFOLIATIVE DERMATITIS; GARDNER SYNDROME; GASTROINTESTINAL CARCINOMA; GENETIC COUNSELING; GENETIC DISORDER; GENODERMATOSIS; HEMATOLOGIC MALIGNANCY; HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; HYPERTHROPHIC OSTEOARTHROPATHY; IMMUNOELECTROPHORESIS; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LESER TRELAT; LOW LEVEL LASER THERAPY; LUNG CANCER; LYMPHOMA; MALIGNANT ACANTHOSIS NIGRICANS; MASTECTOMY; MELANOMA; METASTASIS; MUIR TORRE SYNDROME; MULTICENTRIC RETICULOHISTIOCYTOSIS; NECROBIOTIC XANTHOGRANULOMA; NECROLYTIC MIGRATORY ERYTHEMA; NEUROFIBROMATOSIS; PAGET NIPPLE DISEASE; PAGET SKIN DISEASE; PALLIATIVE THERAPY; PALMOPLANTAR KERATODERMA; PARANEOPLASTIC PEMPHIGUS; PEUTZ JEGHERS SYNDROME; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PHYSICAL EXAMINATION; PRIMARY SYSTEMIC AMYLOIDOSIS; PYODERMA GANGRENOSUM; SCLEROMYXEDEMA; SEBORRHEIC KERATOSIS; SKIN BIOPSY; SKIN CANCER; SKIN DISEASE; SYMPTOMATOLOGY; TREATMENT INDICATION; TRIPE PALMS; TUBEROUS SCLEROSIS; WOUND CARE;

HUMANS; NEOPLASMS; PARANEOPLASTIC SYNDROMES; SKIN DISEASES; SKIN NEOPLASMS;

EID: 77950960226     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1067/j.cpsurg.2010.01.003     Document Type: Article

References (268)

1. Sedano H.O., Gorlin R.J. Acanthosis nigricans. Oral Surg Oral Med Oral Pathol 1987, 63:462-467.
2. Brown J., Winkelmann R.K. Acanthosis nigricans: a study of 90 cases. Medicine (Baltimore) 1968, 47:33-51.
3. Ramirez-Amador V., Esquivel-Pedraza L., Caballero-Mendoza E., Berumen-Campos J., Orozco-Topete R., Angeles-Angeles A. Oral manifestations as a hallmark of malignant acanthosis nigricans. J Oral Pathol Med 1999, 28:278-281.
4. Cohen P.R., Grossman M.E., Silvers D.N., Kurzrock R. Tripe palms and cancer. Clin Dermatol 1993, 11:165-173.
5. Gross G., Pfister H., Hellenthal B., Hagedorn M. Acanthosis nigricans maligna. Clinical and virological investigations. Dermatologica 1984, 168:265-272.
6. Curth H.O. Acanthosis nigricans and its association with cancer. Arch Derm Syphilol 1948, 57:158-170.
7. Hiranandani M., Kaur I., Singhi S.C., Bhoria U. Malignant acanthosis nigricans in adrenal carcinoma. Indian Pediatr 1995, 32:920-923.
8. McGinness J., Greer K. Malignant acanthosis nigricans and tripe palms associated with pancreatic adenocarcinoma. Cutis 2006, 78:37-40.
9. Mohrenschlager M., Vocks E., Wessner D.B., Nahrig J., Ring J. Tripe palms and malignant acanthosis nigricans: cutaneous signs of imminent metastasis in bladder cancer?. J Urol 2001, 165:1629-1630.
10. Chung V.Q., Moschella S.L., Zembowicz A., Liu V. Clinical and pathologic findings of paraneoplastic dermatoses. J Am Acad Dermatol 2006, 54:745-762. quiz 63-6.
11. Dantzig P.I. Sign of leser-trelat. Arch Dermatol 1973, 108:700-701.
12. Holdiness M.R. On the classification of the sign of Leser-Trelat. J Am Acad Dermatol 1988, 19:754-757.
13. Yaniv R., Servadio Y., Feinstein A., Trau H. The sign of Leser-Trelat associated with transitional cell carcinoma of the urinary-bladder-a case report and short review. Clin Exp Dermatol 1994, 19:142-145.
14. Ellis D.L., Yates R.A. Sign of Leser-Trelat. Clin Dermatol 1993, 11:141-148.
15. Ellis D.L., Kafka S.P., Chow J.C., Nanney L.B., Inman W.H., McCadden M.E., et al. Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trelat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. N Engl J Med 1987, 317:1582-1587.
16. Fetil E., Ozkan S., Gurler N., Kusku E., Arda F., Gunes A.T. Recurrent leser-trelat sign associated with two malignancies. Dermatology 2002, 204:254-255.
17. Douglas F., McHenry P.M., Dagg J.H., MacBeth F.M., Morley W.N. Elevated levels of epidermal growth factor in a patient with tripe palms. Br J Dermatol 1994, 130:686-687.
18. Millard L.G., Gould D.J. Hyperkeratosis of the palms and soles associated with internal malignancy and elevated levels of immunoreactive human growth hormone. Clin Exp Dermatol 1976, 1:363-368.
19. Koyama S., Ikeda K., Sato M., Shibahara K., Yuhara K., Fukutomi H., et al. Transforming growth factor-alpha (TGF alpha)-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGF alpha in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus. J Gastroenterol 1997, 32:71-77.
20. Bonnekoh B., Thiele B., Merk H., Mahrle G. Systemic photochemotherapy (PUVA) in acanthosis nigricans maligna: regression of keratosis, hyperpigmentation and pruritus. Z Hautkr 1989, 64:1059-1062.
21. Gorisek B., Krajnc I., Rems D., Kuhelj J. Malignant acanthosis nigricans and tripe palms in a patient with endometrial adenocarcinoma-a case report and review of literature. Gynecol Oncol 1997, 65:539-542.
22. Hazen P.G., Carney J.F., Walker A.E., Stewart J.J. Acanthosis nigricans presenting as hyperkeratosis of the palms and soles. J Am Acad Dermatol 1979, 1:541-544.
23. Skiljevic D.S., Nikolic M.M., Jakovljevic A., Dobrosavljevic D.D. Generalized acanthosis nigricans in early childhood. Pediatr Dermatol 2001, 18:213-216.
24. Howel-Evans W., McConnell C.R., Clarke C.A., Sheppard P.M. Carcinoma of the oesophagus with keratosis palmaris et plantaris (tylosis): a study of two families. Q J Med 1958, 27:413-429.
25. Stevens H.P., Kelsell D.P., Bryant S.P., Bishop D.T., Spurr N.K., Weissenbach J., et al. Linkage of an American pedigree with palmoplantar keratoderma and malignancy (palmoplantar ectodermal dysplasia type III) to 17q24. Literature survey and proposed updated classification of the keratodermas. Arch Dermatol 1996, 132:640-651.
26. Stevens H.P., Kelsell D.P., Leigh I.M., Ostlere L.S., MacDermot K.D., Rustin M.H. Punctate palmoplantar keratoderma and malignancy in a four-generation family. Br J Dermatol 1996, 134:720-726.
27. Patel S., Zirwas M., English J.C. Acquired palmoplantar keratoderma. Am J Clin Dermatol 2007, 8:1-11.
28. Bazex A., Griffiths A. Acrokeratosis paraneoplastica-a new cutaneous marker of malignancy. Br J Dermatol 1980, 103:301-306.
29. Sahin A.A., Karabulut S., Sahin M., Eksioglu M., Ustun H. Paraneoplastic acrokeratosis of Bazex (Bazex's syndrome): report of a female case associated with cholangiocarcinoma and review of the published work. J Dermatol 2006, 33:850-854.
30. Bolognia J.L., Brewer Y.P., Cooper D.L. Bazex syndrome (acrokeratosis paraneoplastica). An analytic review. Medicine (Baltimore) 1991, 70:269-280.
31. Sarkar B., Knecht R., Sarkar C., Weidauer H. Bazex syndrome (acrokeratosis paraneoplastica). Eur Anrch Otorhinolaryngol 1998, 255:205-210.
32. Akhyani M., Mansoori P., Taheri A., Asadi Kani Z. Acrokeratosis paraneoplastica (Bazex syndrome) associated with breast cancer. Clin Exp Dermatol 2004, 29:429-430.
33. Hsu Y.S., Lien G.S., Lai H.H., Cheng Y.S., Hu C.H., Hsieh M.C., et al. Acrokeratosis paraneoplastica (Bazex syndrome) with adenocarcinoma of the colon: report of a case and review of the literature. J Gastroenterol 2000, 35:460-464.
34. Lucker G.P., Steijlen P.M. Acrokeratosis paraneoplastica (Bazex syndrome) occurring with acquired ichthyosis in Hodgkin's disease. Br J Dermatol 1995, 133:322-325.
35. Pecora A.L., Landsman L., Imgrund S.P., Lambert W.C. Acrokeratosis paraneoplastica (Bazex' syndrome). Report of a case and review of the literature. Arch Dermatol 1983, 119:820-826.
36. Jacobsen F.K., Abildtrup N., Laursen S.O., Brandrup F., Jensen N.K. Acrokeratosis paraneoplastica (Bazex' syndrome). Arch Dermatol 1984, 120:502-504.
37. Esteve E., Serpier H., Cambie M.P., Armingaud P., Huet C., Penouil M.H., et al. Bazex paraneoplastic acrokeratosis. Treatment with acitretin. Ann Dermatol Venereol 1995, 122:26-29.
38. Gill D., Fergin P., Kelly J. Bullous lesions in Bazex syndrome and successful treatment with oral psoralen phototherapy. Australas J Dermatol 2001, 42:278-280.
39. Wishart J.M. Bazex paraneoplastic acrokeratosis: a case report and response to Tigason. Br J Dermatol 1986, 115:595-599.
40. Schwartz R.A., Williams M.L. Acquired ichthyosis: a marker for internal disease. Am Fam Physician 1984, 29:181-184.
41. Aram H. Acquired ichthyosis and related conditions. Int J Dermatol 1984, 23:458-461.
42. Eisman S., O'Toole E.A., Jones A., Whittaker S.J. Granulomatous mycosis fungoides presenting as an acquired ichthyosis. Clin Exp Dermatol 2003, 28:174-176.
43. van D. Ichthyosiform atrophy of the skin associated with internal malignant diseases. Dermatologica 1963, 127:413-428.
44. Ameen M., Chopra S., Darvay A., Acland K., Chu A.C. Erythema gyratum repens and acquired ichthyosis associated with transitional cell carcinoma of the kidney. Clin Exp Dermatol 2001, 26:510-512.
45. Farrell A.M., Ross J.S., Thomas J.M., Fisher C., Bunker C.B. Acquired ichthyosis, alopecia and loss of hair pigment associated with leiomyosarcoma. J Eur Acad Dermatol Venereol 1998, 10:159-163.
46. Inuzuka M., Tomita K., Tokura Y., Takigawa M. Acquired ichthyosis associated with dermatomyositis in a patient with hepatocellular carcinoma. Br J Dermatol 2001, 144:416-417.
47. Roselino A.M., Souza C.S., Andrade J.M., Tone L.G., Soares F.A., Llorach-Velludo M.A., et al. Dermatomyositis and acquired ichthyosis as paraneoplastic manifestations of ovarian tumor. Int J Dermatol 1997, 36:611-614.
48. Stevanovic D.V. Hodgkin's disease of the skin. Acquired ichthyosis preceding tumoral and ulcerating lesions for seven years. Arch Dermatol 1960, 82:96-99.
49. Griffin L.J., Massa M.C. Acquired ichthyosis and Pityriasis rotunda. Clin Dermatol 1993, 11:27-32.
50. Eubanks L.E., McBurney E., Reed R. Erythema gyratum repens. Am J Med Sci 2001, 321:302-305.
51. Boyd A.S., Neldner K.H., Menter A. Erythema gyratum repens: a paraneoplastic eruption. J Am Acad Dermatol 1992, 26:757-762.
52. Miyagawa F., Danno K., Uehara M. Erythema gyratum repens responding to cetirizine hydrochloride. J Dermatol 2002, 29:731-734.
53. Cohen P.R. Sweet's syndrome-a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2007, 2:34.
54. Sweet R.D. An acute febrile neutrophilic dermatosis. Br J Dermatol 1964, 76:349-356.
55. Cohen P.R., Holder W.R., Rapini R.P. Concurrent Sweet's syndrome and erythema nodosum: a report, world literature review and mechanism of pathogenesis. J Rheumatol 1992, 19:814-820.
56. Ratzinger G., Burgdorf W., Zelger B.G., Zelger B. Acute febrile neutrophilic dermatosis: a histopathologic study of 31 cases with review of literature. Am J Dermatopathol 2007, 29:125-133.
57. Buck T., Gonzalez L.M., Lambert W.C., Schwartz R.A. Sweet's syndrome with hematologic disorders: a review and reappraisal. Int J Dermatol 2008, 47:775-782.
58. Cohen P.R., Holder W.R., Tucker S.B., Kono S., Kurzrock R. Sweet syndrome in patients with solid tumors. Cancer 1993, 72:2723-2731.
59. Kawakami T., Ohashi S., Kawa Y., Takahama H., Ito M., Soma Y., et al. Elevated serum granulocyte colony-stimulating factor levels in patients with active phase of Sweet syndrome and patients with active Behcet disease: implication in neutrophil apoptosis dysfunction. Arch Dermatol 2004, 140:570-574.
60. Watari K., Tojo A., Nagamura-Inoue T., Matsuoka M., Irie S., Tani K., et al. Hyperfunction of neutrophils in a patient with BCR/ABL negative chronic myeloid leukemia: a case report with in vitro studies. Cancer 2000, 89:551-560.
61. Cohen P.R. Neutrophilic dermatoses: a review of current treatment options. Am J Clin Dermatol 2009, 10:301-312.
62. Callen J.P., Jackson J.M. Pyoderma gangrenosum: an update. Rheum Dis Clin North Am 2007, 33:787-802. vi.
63. Reguiai Z., Grange F. The role of anti-tumor necrosis factor-alpha therapy in pyoderma gangrenosum associated with inflammatory bowel disease. Am J Clin Dermatol 2007, 8:67-77.
64. Su W.P., Davis M.D., Weenig R.H., Powell F.C., Perry H.O. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol 2004, 43:790-800.
65. Vidal D., Puig L., Gilaberte M., Alomar A. Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features. J Dermatolog Treat 2004, 15:146-152.
66. Brown T.S., Marshall G.S., Callen J.P. Cavitating pulmonary infiltrate in an adolescent with pyoderma gangrenosum: a rarely recognized extracutaneous manifestation of a neutrophilic dermatosis. J Am Acad Dermatol 2000, 43:108-112.
67. Weenig R.H., Davis M.D., Dahl P.R., Su W.P. Skin ulcers misdiagnosed as pyoderma gangrenosum. N Engl J Med 2002, 347:1412-1418.
68. Bennett M.L., Jackson J.M., Jorizzo J.L., Fleischer A.B., White W.L., Callen J.P. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore) 2000, 79:37-46.
69. Reichrath J., Bens G., Bonowitz A., Tilgen W. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 2005, 53:273-283.
70. Duguid C.M., Powell F.C. Pyoderma gangrenosum. Clin Dermatol 1993, 11:129-133.
71. Cummins D.L., Anhalt G.J., Monahan T., Meyerle J.H. Treatment of pyoderma gangrenosum with intravenous immunoglobulin. Br J Dermatol 2007, 157:1235-1239.
72. Ehling A., Karrer S., Klebl F., Schaffler A., Muller-Ladner U. Therapeutic management of pyoderma gangrenosum. Arthritis Rheum 2004, 50:3076-3084.
73. Iorizzo L.J., Jorizzo J.L. The treatment and prognosis of dermatomyositis: an updated review. J Am Acad Dermatol 2008, 59:99-112.
74. Kovacs S.O., Kovacs S.C. Dermatomyositis. J Am Acad Dermatol 1998, 39:899-920. quiz 921-2.
75. Smith E.S., Hallman J.R., DeLuca A.M., Goldenberg G., Jorizzo J.L., Sangueza O.P. Dermatomyositis: a clinicopathological study of 40 patients. Am J Dermatopathol 2009, 31:61-67.
76. Walker U.A. Imaging tools for the clinical assessment of idiopathic inflammatory myositis. Curr Opin Rheumatol 2008, 20:656-661.
77. Gunawardena H., Betteridge Z.E., McHugh N.J. Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression. Rheumatology (Oxford) 2009, 48:607-612.
78. Madan V., Chinoy H., Griffiths C.E., Cooper R.G. Defining cancer risk in dermatomyositis. Part I. Clin Exp Dermatol 2009, 34:451-455.
79. Airio A., Pukkala E., Isomaki H. Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol 1995, 22:1300-1303.
80. Hill C.L., Zhang Y., Sigurgeirsson B., Pukkala E., Mellemkjaer L., Airio A., et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001, 357:96-100.
81. Seidler A.M., Gottlieb A.B. Dermatomyositis induced by drug therapy: a review of case reports. J Am Acad Dermatol 2008, 59:872-880.
82. Anhalt G.J., Kim S.C., Stanley J.R., Korman N.J., Jabs D.A., Kory M., et al. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990, 323:1729-1735.
83. Sehgal V.N., Srivastava G. Paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome. Int J Dermatol 2009, 48:162-169.
84. Joly P., Richard C., Gilbert D., Courville P., Chosidow O., Roujeau J.C., et al. Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol 2000, 43:619-626.
85. Mimouni D., Anhalt G.J., Lazarova Z., Aho S., Kazerounian S., Kouba D.J., et al. Paraneoplastic pemphigus in children and adolescents. Br J Dermatol 2002, 147:725-732.
86. Cummins D.L., Mimouni D., Tzu J., Owens N., Anhalt G.J., Meyerle J.H. Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies. J Am Acad Dermatol 2007, 56:153-159.
87. Nguyen V.T., Ndoye A., Bassler K.D., Shultz L.D., Shields M.C., Ruben B.S., et al. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus. Arch Dermatol 2001, 137:193-206.
88. Camisa C., Helm T.N. Paraneoplastic pemphigus is a distinct neoplasia-induced autoimmune disease. Arch Dermatol 1993, 129:883-886.
89. Ahmed A.R., Avram M.M., Duncan L.M. Weekly clinicopathological exercises. Case 23-2003. N Engl J Med 2003, 349:382-391. Case records of the Massachusetts General Hospital, A 79-year-old woman with gastric lymphoma and erosive mucosal and cutaneous lesions.
90. Kaplan I., Hodak E., Ackerman L., Mimouni D., Anhalt G.J., Calderon S. Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations. Oral Oncol 2004, 40:553-562.
91. Eccersley L.R., Hoffbrand A.V., Rustin M.H., McNamara C.J. Paraneoplastic pemphigus associated with systemic mastocytosis. Am J Hematol 2009, 84:847-848.
92. Anhalt G.J. Paraneoplastic pemphigus. Adv Dermatol 1997, 12:77-96. discussion 97.
93. Heizmann M., Itin P., Wernli M., Borradori L., Bargetzi M.J. Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL. Am J Hematol 2001, 66:142-144.
94. Hohwy T., Bang K., Steiniche T., Peterslund N.A., d'Amore F. Alemtuzumab-induced remission of both severe paraneoplastic pemphigus and leukaemic bone marrow infiltration in a case of treatment-resistant B-cell chronic lymphocytic leukaemia. Eur J Haematol 2004, 73:206-209.
95. Kossard S., Winkelmann R.K. Necrobiotic xanthogranuloma with paraproteinemia. J Am Acad Dermatol 1980, 3:257-270.
96. Spicknall K.E., Mehregan D.A. Necrobiotic xanthogranuloma. Int J Dermatol 2009, 48:1-10.
97. Mehregan D.A., Winkelmann R.K. Necrobiotic xanthogranuloma. Arch Dermatol 1992, 128:94-100.
98. Wood A.J., Wagner M.V., Abbott J.J., Gibson L.E. Necrobiotic xanthogranuloma: a review of 17 cases with emphasis on clinical and pathologic correlation. Arch Dermatol 2009, 145:279-284.
99. Ugurlu S., Bartley G.B., Gibson L.E. Necrobiotic xanthogranuloma: long-term outcome of ocular and systemic involvement. Am J Ophthalmol 2000, 129:651-657.
100. Zainal A., Razif M.Y., Makhashen M., Swaminathan M., Mazita A. Necrobiotic xanthogranuloma of the parotid gland. J Laryngol Otol 2009, 1-3.
101. Finan M.C., Winkelmann R.K. Histopathology of necrobiotic xanthogranuloma with paraproteinemia. J Cutan Pathol 1987, 14:92-99.
102. Zelger B., Eisendle K., Mensing C. Detection of spirochetal micro-organisms by focus-floating microscopy in necrobiotic xanthogranuloma. J Am Acad Dermatol 2007, 57:1026-1030.
103. Flann S., Wain E.M., Halpern S., Andrews V., Whittaker S. Necrobiotic xanthogranuloma with paraproteinaemia. Clin Exp Dermatol 2006, 31:248-251.
104. Goede J.S., Misselwitz B., Taverna C., Schanz U., Dispenzieri A., Hummel Y., et al. Necrobiotic xanthogranuloma successfully treated with autologous stem cell transplantation. Ann Hematol 2007, 86:303-306.
105. Schaudig U., Al-Samir K. Upper and lower eyelid reconstruction for severe disfiguring necrobiotic xanthogranuloma. Orbit 2004, 23:65-76.
106. Luz F.B., Gaspar N.K., Gaspar A.P., Carneiro S., Ramos-e-Silva M. Multicentric reticulohistiocytosis: a proliferation of macrophages with tropism for skin and joints, part I. Skinmed 2007, 6:172-178.
107. Trotta F., Castellino G., Lo Monaco A. Multicentric reticulohistiocytosis. Best Pract Res Clin Rheumatol 2004, 18:759-772.
108. Luz F.B., Gaspar T.A.P., Kalil-Gaspar N., Ramos-e-Silva M. Multicentric reticulohistiocytosis. J Eur Acad Dermatol Venereol 2001, 15:524-531.
109. Munoz-Santos C., Sabat M., Saez A., Gratacos J., Luelmo J. Multicentric reticulohistiocytosis-mimicking dermatomyositis. Case report and review of the literature. Dermatology 2007, 214:268-271.
110. Kalajian A.H., Callen J.P. Multicentric reticulohistiocytosis successfully treated with infliximab: an illustrative case and evaluation of cytokine expression supporting anti-tumor necrosis factor therapy. Arch Dermatol 2008, 144:1360-1366.
111. Luz F.B., Gaspar N.K., Gaspar A.P., Carneiro S., Ramos-E-Silva M. Multicentric reticulohistiocytosis: a proliferation of macrophages with tropism for skin and joints, part II. Skinmed 2007, 6:227-233.
112. Snow J.L., Muller S.A. Malignancy-associated multicentric reticulohistiocytosis: a clinical, histological and immunophenotypic study. Br J Dermatol 1995, 133:71-76.
113. Millar A., O'Kane D., Taggart A. Multicentric reticulohistiocytosis: a lesson in screening for malignancy. Rheumatology (Oxford) 2008, 47:1102-1103.
114. Brackenridge A., Bashir T., Wheatley T. Multicentric reticulohistiocytosis and pregnancy. BJOG 2005, 112:672-673.
115. Codriansky K.A., Runger T.M., Bhawan J., Kantarci A., Kissin E.Y. Multicentric reticulohistiocytosis: a systemic osteoclastic disease?. Arthritis Rheum 2008, 59:444-448.
116. Lonsdale-Eccles A.A., Haworth A.E., McCrae F.C., Young-Min S.A. Successful treatment of multicentric reticulohistiocytosis with leflunomide. Br J Dermatol 2009, 161:470-472.
117. Gertz M.A., Lacy M.Q., Dispenzieri A. Amyloidosis: recognition, confirmation, prognosis, and therapy. Mayo Clin Proc 1999, 74:490-494.
118. Silverstein S.R. Primary, systemic amyloidosis and the dermatologist: where classic skin lesions may provide the clue for early diagnosis. Dermatol Online J 2005, 11:5.
119. Breathnach S.M. Amyloid and amyloidosis. J Am Acad Dermatol 1988, 18:1-16.
120. Comenzo R.L. Primary systemic amyloidosis. Curr Treat Options Oncol 2000, 1:83-89.
121. Kyle R.A., Gertz M.A., Greipp P.R., Witzig T.E., Lust J.A., Lacy M.Q., et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med 1997, 336:1202-1207.
122. Mhaskar R., Kumar A., Behera M., Kharfan-Dabaja M.A., Djulbegovic B. Role of high-dose chemotherapy and autologous hematopoietic cell transplantation in primary systemic amyloidosis: a systematic review. Biol Blood Marrow Transplant 2009, 15:893-902.
123. Dinneen A.M., Dicken C.H. Scleromyxedema. J Am Acad Dermatol 1995, 33:37-43.
124. Cokonis Georgakis C.D., Falasca G., Georgakis A., Heymann W.R. Scleromyxedema. Clin Dermatol 2006, 24:493-497.
125. Pomann J.J., Rudner E.J. Scleromyxedema revisited. Int J Dermatol 2003, 42:31-35.
126. Rongioletti F., Rebora A. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol 2001, 44:273-281.
127. Harper R.A., Rispler J. Lichen myxedematosus serum stimulates human skin fibroblast proliferation. Science 1978, 199:545-547.
128. Ataergin S., Arpaci F., Demiriz M., Ozet A. Transient efficacy of double high-dose chemotherapy and autologous peripheral stem cell transplantation, immunoglobulin, thalidomide, and bortezomib in the treatment of scleromyxedema. Am J Clin Dermatol 2008, 9:271-273.
129. Rey J.B., Luria R.B. Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin. J Am Acad Dermatol 2009, 60:1037-1041.
130. Acikel C., Karagoz H., Kucukodaci Z. Surgical treatment of facial disfigurement due to lichen myxedematosus. Dermatol Surg 2009, 35:875-877.
131. Kleyn C.E., Lai-Cheong J.E., Bell H.K. Cutaneous manifestations of internal malignancy: diagnosis and management. Am J Clin Dermatol 2006, 7:71-84.
132. Thiers B.H., Sahn R.E., Callen J.P. Cutaneous manifestations of internal malignancy. CA Cancer J Clin 2009, 59:73-98.
133. Kindmark H., Sundin A., Granberg D., Dunder K., Skogseid B., Janson E.T., et al. Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years. Med Oncol 2007, 24:330-337.
134. Mignogna M.D., Fortuna G., Satriano A.R. Small-cell lung cancer and necrolytic migratory erythema. N Engl J Med 2008, 359:2731-2732.
135. Moertel C.G., Kvols L.K., O'Connell M.J., Rubin J. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer 1991, 68:227-232.
136. Arnold R., Frank M., Kajdan U. Management of gastroenteropancreatic endocrine tumors: the place of somatostatin analogues. Digestion 1994, 55(suppl 3):107-113.
137. Frank M., Klose K.J., Wied M., Ishaque N., Schade-Brittinger C., Arnold R. Combination therapy with octreotide and alpha-interferon: effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors. Am J Gastroenterol 1999, 94:1381-1387.
138. Radny P., Eigentler T.K., Soennichsen K., Overkamp D., Raab H.R., Viebahn R., et al. Metastatic glucagonoma: treatment with liver transplantation. J Am Acad Dermatol 2006, 54:344-347.
139. Rosen T., Chappell R., Drucker C. Exfoliative dermatitis: presenting sign of internal malignancy. South Med J 1979, 72:652-653.
140. Chong V.H., Lim C.C. Erythroderma as the first manifestation of colon cancer. South Med J 2009, 102:334-335.
141. Etter L., Myers S.A. Pruritus in systemic disease: mechanisms and management. Dermatol Clin 2002, 20:459-472. vi-vii.
142. Hiramanek N. Itch: a symptom of occult disease. Aust Fam Physician 2004, 33:495-499.
143. Twycross R., Greaves M.W., Handwerker H., Jones E.A., Libretto S.E., Szepietowski J.C., et al. Itch: scratching more than the surface. QJM 2003, 96:7-26.
144. Farina M.C., Tarin N., Grilli R., Soriano M.L., Sarasa J.L., Martin L., et al. Acquired hypertrichosis lanuginosa: case report and review of the literature. J Surg Oncol 1998, 68:199-203.
145. Perez-Losada E., Pujol R.M., Domingo P., Matias-Guiu X., Lenti J., Lopez-Pousa A., et al. Hypertrichosis lanuginosa acquisita preceding extraskeletal Ewing's sarcoma. Clin Exp Dermatol 2001, 26:182-183.
146. Slee P.H., van der Waal R.I., Schagen van Leeuwen J.H., Tupker R.A., Timmer R., Seldenrijk C.A., et al. Paraneoplastic hypertrichosis lanuginosa acquisita: uncommon or overlooked?. Br J Dermatol 2007, 157:1087-1092.
147. Hansen-Flaschen J., Nordberg J. Clubbing and hypertrophic osteoarthropathy. Clin Chest Med 1987, 8:287-298.
148. Cohen P.R. Hypertrophic pulmonary osteoarthropathy and tripe palms in a man with squamous cell carcinoma of the larynx and lung. Report of a case and review of cutaneous paraneoplastic syndromes associated with laryngeal and lung malignancies. Am J Clin Oncol 1993, 16:268-276.
149. Yao Q., Altman R.D., Brahn E. Periostitis and hypertrophic pulmonary osteoarthropathy: report of 2 cases and review of the literature. Semin Arthritis Rheum 2009, 38:458-466.
150. Handley J., Walsh M., Armstrong K., Russell C., Buchanan K., Bingham A. Malignant carcinoid syndrome associated with cutaneous scleroderma. Br J Dermatol 1993, 129:222-223.
151. Rajamannan N.M., Caplice N., Anthikad F., Sebo T.J., Orszulak T.A., Edwards W.D., et al. Cell proliferation in carcinoid valve disease: a mechanism for serotonin effects. J Heart Valve Dis 2001, 10:827-831.
152. Feingold K.R., Elias P.M. Endocrine-skin interactions. Cutaneous manifestations of adrenal disease, pheochromocytomas, carcinoid syndrome, sex hormone excess and deficiency, polyglandular autoimmune syndromes, multiple endocrine neoplasia syndromes, and other miscellaneous disorders. J Am Acad Dermatol 1988, 19:1-20.
153. Zeitlin I.J., Smith A.N. 5-hydroxyindoles and kinins in the carcinoid and dumping syndromes. Lancet 1966, 2:986-991.
154. O'Connor D.T., Deftos L.J. Secretion of chromogranin A by peptide-producing endocrine neoplasms. N Engl J Med 1986, 314:1145-1151.
155. Maroun J., Kocha W., Kvols L., Bjarnason G., Chen E., Germond C., et al. Guidelines for the diagnosis and management of carcinoid tumours. Part 1: the gastrointestinal tract. Curr Oncol 2006, 13:67-76. A statement from a Canadian National Carcinoid Expert Group.
156. Raut C.P., Kulke M.H., Glickman J.N., Swanson R.S., Ashley S.W. Carcinoid tumors. Curr Probl Surg 2006, 43:383-450.
157. Fu W., Mittel V.K., Young S.C. Paget disease of the breast: analysis of 41 patients. Am J Clin Oncol 2001, 24:397-400.
158. Lancer H.A., Moschella S.L. Paget's disease of the male breast. J Am Acad Dermatol 1982, 7:393-396.
159. Kao G.F., Graham J.H., Helwig E.B. Paget's disease of the ectopic breast with an underlying intraductal carcinoma: report of a case. J Cutan Pathol 1986, 13:59-66.
160. Martin V.G., Pellettiere E.V., Gress D., Miller A.W. Paget's disease in an adolescent arising in a supernumerary nipple. J Cutan Pathol 1994, 21:283-286.
161. Cooper S.M., Wojnarowska F. Anogenital (non-venereal) disease. Dermatology 2008, 1067-1068. Mosby Elsevier, Spain. 2nd ed. J.L. Bolognia, J.L. Jorizzo, R.P. Rapini (Eds.).
162. Braverman I.M. Skin manifestations of internal malignancy. Clin Geriatr Med 2002, 18:1-19. v.
163. Pinero A., Illana J., Martinez-Barba E., Sola J., Parrilla P. Extramammary Paget's disease of the breast: an unusual location with prognostic implications. Breast 2005, 14:388-391.
164. Pierie J.P., Choudry U., Muzikansky A., Finkelstein D.M., Ott M.J. Prognosis and management of extramammary Paget's disease and the association with secondary malignancies. J Am Coll Surg 2003, 196:45-50.
165. Zollo J.D., Zeitouni N.C. The Roswell Park Cancer Institute experience with extramammary Paget's disease. Br J Dermatol 2000, 142:59-65.
166. Schwartz R.A. Cutaneous metastatic disease. J Am Acad Dermatol 1995, 33:161-182. quiz 83-6.
167. Lloyd J., Flanagan A.M. Mammary and extramammary Paget's disease. J Clin Pathol 2000, 53:742-749.
168. Yang W.J., Kim D.S., Im Y.J., Cho K.S., Rha K.H., Cho N.H., et al. Extramammary Paget's disease of penis and scrotum. Urology 2005, 65:972-975.
169. Coldiron B.M., Goldsmith B.A., Robinson J.K. Surgical treatment of extramammary Paget's disease. A report of six cases and a reexamination of Mohs micrographic surgery compared with conventional surgical excision. Cancer 1991, 67:933-938.
170. Oster M.W., Magun A., Herter F.P., Wolff M. Colorectal carcinoma 15 years after the diagnosis of perianal Paget disease. J Surg Oncol 1979, 12:379-384.
171. Lookingbill D.P., Spangler N., Helm K.F. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol 1993, 29:228-236.
172. Krathen R.A., Orengo I.F., Rosen T. Cutaneous metastasis: a meta-analysis of data. South Med J 2003, 96:164-167.
173. Davis D., Pellowski D. Cutaneous metastases. Dermatology 2008, 1897-1901. Mosby Elsevier, Spain. 2nd ed. J.L. Bolognia, J.L. Jorizzo, R.P. Rapini (Eds.).
174. Pizzichetta M.A. Cutaneous metastatic melanoma. Color atlas of melanocytic lesions of the skin 2007, 260-264. Springer, New York. H.P. Soyer, G. Argenziano, R. Hofmann-Wellenhof, R.H. Johr (Eds.).
175. Saeed S., Keehn C.A., Morgan M.B. Cutaneous metastasis: a clinical, pathological, and immunohistochemical appraisal. J Cutan Pathol 2004, 31:419-430.
176. Dorairajan L.N., Hemal A.K., Aron M., Rajeev T.P., Nair M., Seth A., et al. Cutaneous metastases in renal cell carcinoma. Urol Int 1999, 63:164-167.
177. Brownstein M.H., Helwig E.B. Spread of tumors to the skin. Arch Dermatol 1973, 107:80-86.
178. Singletary S.E., Cristofanilli M. Defining the clinical diagnosis of inflammatory breast cancer. Semin Oncol 2008, 35:7-10.
179. Mollet T.W., Garcia C.A., Koester G. Skin metastases from lung cancer. Dermatol Online J 2009, 15:1.
180. Terashima T., Kanazawa M. Lung cancer with skin metastasis. Chest 1994, 106:1448-1450.
181. Lookingbill D.P., Spangler N., Sexton F.M. Skin involvement as the presenting sign of internal carcinoma. A retrospective study of 7316 cancer patients. J Am Acad Dermatol 1990, 22:19-26.
182. Kamble R., Kumar L., Kochupillai V., Sharma A., Sandhoo M.S., Mohanti B.K. Cutaneous metastases of lung cancer. Postgrad Med J 1995, 71:741-743.
183. Esaki Y., Hirayama R., Hirokawa K. A comparison of patterns of metastasis in gastric cancer by histologic type and age. Cancer 1990, 65:2086-2090.
184. Xavier M.H., Vergueiro Tde R., Vilar E.G., Pinto J.M., Issa M.C., Pereira G.B., et al. Cutaneous metastasis of gastric adenocarcinoma: an exuberant and unusual clinical presentation. Dermatol Online J 2008, 14:8.
185. Lim C., Chan R., Regan W. Renal cell carcinoma with cutaneous metastases. Australas J Dermatol 2005, 46:158-160.
186. Morton D.L., Cochran A.J., Thompson J.F., Elashoff R., Essner R., Glass E.C., et al. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 2005, 242:302-311.
187. Smoller B.R. Other lymphoproliferative and myeloproliferative diseases. Dermatology 2008, 1891-1892. Mosby Elsevier, Spain. 2nd ed. J.L. Bolognia, J.L. Jorizzo, R.P. Rapini (Eds.).
188. Ratnam K.V., Khor C.J., Su W.P. Leukemia cutis. Dermatol Clin 1994, 12:419-431.
189. Cerroni L., Fink-Puches R., Back B., Kerl H. Follicular mucinosis: a critical reappraisal of clinicopathologic features and association with mycosis fungoides and Sezary syndrome. Arch Dermatol 2002, 138:182-189.
190. van Doorn R., van Haselen C.W., van Voorst Vader P.C., Geerts M.L., Heule F., de Rie M., et al. Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients. Arch Dermatol 2000, 136:504-510.
191. Kim Y.H., Hoppe R.T. Mycosis fungoides and the Sezary syndrome. Semin Oncol 1999, 26:276-289.
192. Jurisic V., Bogunovic M., Colovic N., Colovic M. Indolent course of the cutaneous Hodgkin's disease. J Cutan Pathol 2005, 32:176-178.
193. Smith J.L., Butler J.J. Skin involvement in Hodgkin's disease. Cancer 1980, 45:354-361.
194. Matutes E. Adult T-cell leukaemia/lymphoma. J Clin Pathol 2007, 60:1373-1377.
195. Desch J.K., Smoller B.R. The spectrum of cutaneous disease in leukemias. J Cutan Pathol 1993, 20:407-410.
196. Cho-Vega J.H., Medeiros L.J., Prieto V.G., Vega F. Leukemia cutis. Am J Clin Pathol 2008, 129:130-142.
197. Wilkins R., Janes S. Aleukaemic leukaemia cutis: case report and review of the literature. Clin Lab Haematol 2004, 26:73-75.
198. Su W.P. Clinical, histopathologic, and immunohistochemical correlations in leukemia cutis. Semin Dermatol 1994, 13:223-230.
199. Schmults C.A. Leukemia cutis (chronic lymphocytic leukemia-low grade B cell). Dermatol Online J 2002, 8:14.
200. Zhang I.H., Zane L.T., Braun B.S., Maize J., Zoger S., Loh M.L. Congenital leukemia cutis with subsequent development of leukemia. J Am Acad Dermatol 2006, 54:S22-S27.
201. Nelen M.R., Kremer H., Konings I.B., Schoute F., van Essen A.J., Koch R., et al. Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations. Eur J Hum Genet 1999, 7:267-273.
202. Salem O.S., Steck W.D. Cowden's disease (multiple hamartoma and neoplasia syndrome). A case report and review of the English literature. J Am Acad Dermatol 1983, 8:686-696.
203. Starink T.M., van der Veen J.P., Arwert F., de Waal L.P., de Lange G.G., Gille J.J., et al. The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet 1986, 29:222-233.
204. Requena L., Gutierrez J., Sanchez Yus E. Multiple sclerotic fibromas of the skin. A cutaneous marker of Cowden's disease. J Cutan Pathol 1992, 19:346-351.
205. Pilarski R. Cowden syndrome: a critical review of the clinical literature. J Genet Couns 2009, 18:13-27.
206. Fackenthal J.D., Marsh D.J., Richardson A.L., Cummings S.A., Eng C., Robinson B.G., et al. Male breast cancer in Cowden syndrome patients with germline PTEN mutations. J Med Genet 2001, 38:159-164.
207. Marsh D.J., Coulon V., Lunetta K.L., Rocca-Serra P., Dahia P.L., Zheng Z., et al. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet 1998, 7:507-515.
208. Eng C. Cowden syndrome. J Genet Couns 1997, 6:181-192.
209. Harach H.R., Soubeyran I., Brown A., Bonneau D., Longy M. Thyroid pathologic findings in patients with Cowden disease. Ann Diagn Pathol 1999, 3:331-340.
210. Nelen M.R., Padberg G.W., Peeters E.A., Lin A.Y., van den Helm B., Frants R.R., et al. Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet 1996, 13:114-116.
211. Tamguney T., Stokoe D. New insights into PTEN. J Cell Sci 2007, 120:4071-4079.
212. Schwartz R.A., Torre D.P. The Muir-Torre syndrome: a 25-year retrospect. J Am Acad Dermatol 1995, 33:90-104.
213. Cohen P.R., Kohn S.R., Kurzrock R. Association of sebaceous gland tumors and internal malignancy: the Muir-Torre syndrome. Am J Med 1991, 90:606-613.
214. Cohen P.R., Kohn S.R., Davis D.A., Kurzrock R. Muir-Torre syndrome. Dermatol Clin 1995, 13:79-89.
215. Coldron J., Reid I. Muir-Torre syndrome. J R Coll Surg Edinb 2001, 46:178-179.
216. Jones B., Oh C., Mangold E., Egan C.A. Muir-Torre syndrome: diagnostic and screening guidelines. Australas J Dermatol 2006, 47:266-269.
217. Bilkay U., Erdem O., Ozek C., Helvaci E., Kilic K., Ertan Y., et al. Benign osteoma with Gardner syndrome: review of the literature and report of a case. J Craniofac Surg 2004, 15:506-509.
218. Jones I.T., Jagelman D.G., Fazio V.W., Lavery I.C., Weakley F.L., McGannon E. Desmoid tumors in familial polyposis coli. Ann Surg 1986, 204:94-97.
219. Nandakumar G., Morgan J.A., Silverberg D., Steinhagen R.M. Familial polyposis coli: clinical manifestations, evaluation, management and treatment. Mt Sinai J Med 2004, 71:384-391.
220. Gruner B.A., DeNapoli T.S., Andrews W., Tomlinson G., Bowman L., Weitman S.D. Hepatocellular carcinoma in children associated with Gardner syndrome or familial adenomatous polyposis. J Pediatr Hematol Oncol 1998, 20:274-278.
221. Ascari-Raccagni A., Baldari U., Righini M.G. Cutaneous symptoms of Gardner's syndrome. J Eur Acad Dermatol Venereol 1999, 12:80-81.
222. Parisi M.L. Congenital hypertrophy of the retinal pigment epithelium serves as a clinical marker in a family with familial adenomatous polyposis. J Am Optom Assoc 1995, 66:106-112.
223. Shields J.A., Shields C.L., Shah P.G., Pastore D.J., Imperiale S.M. Lack of association among typical congenital hypertrophy of the retinal pigment epithelium, adenomatous polyposis, and Gardner syndrome. Ophthalmology 1992, 99:1709-1713.
224. Huson S.M., Compston D.A., Clark P., Harper P.S. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 1989, 26:704-711.
225. Gutmann D.H., Aylsworth A., Carey J.C., Korf B., Marks J., Pyeritz R.E., et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997, 278:51-57.
226. DeBella K., Szudek J., Friedman J.M. Use of the National Institutes of Health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics 2000, 105:608-614.
227. Otsuka F., Kawashima T., Imakado S., Usuki Y., Hon-Mura S. Lisch nodules and skin manifestation in neurofibromatosis type 1. Arch Dermatol 2001, 137:232-233.
228. Storm F.K., Eilber F.R., Mirra J., Morton D.L. Neurofibrosarcoma. Cancer 1980, 45:126-129.
229. Zvulunov A., Barak Y., Metzker A. Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis. Arch Dermatol 1995, 131:904-908.
230. Blatt J., Jaffe R., Deutsch M., Adkins J.C. Neurofibromatosis and childhood tumors. Cancer 1986, 57:1225-1229.
231. Akbarnia B.A., Gabriel K.R., Beckman E., Chalk D. Prevalence of scoliosis in neurofibromatosis. Spine (Phila Pa 1976) 1992, 17:S244-S248.
232. White A.K., Smith R.J., Bigler C.R., Brooke W.F., Schauer P.R. Head and neck manifestations of neurofibromatosis. Laryngoscope 1986, 96:732-737.
233. Riccardi V.M., Lewis R.A. Penetrance of von Recklinghausen neurofibromatosis: a distinction between predecessors and descendants. Am J Hum Genet 1988, 42:284-289.
234. Wigler M.H. Oncoproteins. GAPs in understanding Ras. Nature 1990, 346:696-697.
235. Birt A.R., Hogg G.R., Dube W.J. Hereditary multiple fibrofolliculomas with trichodiscomas and acrochordons. Arch Dermatol 1977, 113:1674-1677.
236. Toro J.R., Wei M.H., Glenn G.M., Weinreich M., Toure O., Vocke C., et al. BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dube syndrome: a new series of 50 families and a review of published reports. J Med Genet 2008, 45:321-331.
237. de la Torre C., Ocampo C., Doval I.G., Losada A., Cruces M.J. Acrochordons are not a component of the Birt-Hogg-Dube syndrome: does this syndrome exist?. Case reports and review of the literature. Am J Dermatopathol 1999, 21:369-374.
238. Vincent A., Farley M., Chan E., James W.D. Birt-Hogg-Dube syndrome: a review of the literature and the differential diagnosis of firm facial papules. J Am Acad Dermatol 2003, 49:698-705.
239. Chung J.Y., Ramos-Caro F.A., Beers B., Ford M.J., Flowers F. Multiple lipomas, angiolipomas, and parathyroid adenomas in a patient with Birt-Hogg-Dube syndrome. Int J Dermatol 1996, 35:365-367.
240. Shapiro P.E., Kopf A.W. Familial multiple desmoplastic trichoepitheliomas. Arch Dermatol 1991, 127:83-87.
241. Pavlovich C.P., Walther M.M., Eyler R.A., Hewitt S.M., Zbar B., Linehan W.M., et al. Renal tumors in the Birt-Hogg-Dube syndrome. Am J Surg Pathol 2002, 26:1542-1552.
242. Rongioletti F., Hazini R., Gianotti G., Rebora A. Fibrofolliculomas, tricodiscomas and acrochordons (Birt-Hogg-Dube) associated with intestinal polyposis. Clin Exp Dermatol 1989, 14:72-74.
243. Zbar B., Alvord W.G., Glenn G., Turner M., Pavlovich C.P., Schmidt L., et al. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dube syndrome. Cancer Epidemiol Biomarkers Prev 2002, 11:393-400.
244. Schmidt L.S., Warren M.B., Nickerson M.L., Weirich G., Matrosova V., Toro J.R., et al. Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2. Am J Hum Genet 2001, 69:876-882.
245. Gupta P., Eshaghi N., Kamba T.T., Ghole V., Garcia-Morales F. Radiological findings in Birt-Hogg-Dube syndrome: a rare differential for pulmonary cysts and renal tumors. Clin Imaging 2007, 31:40-43.
246. Kim E.H., Jeong S.Y., Kim H.J., Kim Y.C. A case of Birt-Hogg-Dube syndrome. J Korean Med Sci 2008, 23:332-335.
247. Alam N.A., Olpin S., Leigh I.M. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer. Br J Dermatol 2005, 153:11-17.
248. Launonen V., Vierimaa O., Kiuru M., Isola J., Roth S., Pukkala E., et al. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci U S A 2001, 98:3387-3392.
249. Tomlinson I.P., Alam N.A., Rowan A.J., Barclay E., Jaeger E.E., Kelsell D., et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 2002, 30:406-410.
250. Barnhill R.L., Rabinovitz H. Benign melanocytic neoplasms. Dermatology 2008, 1717-1720. Mosby, Spain. 2nd ed. J.L. Bolognia, J.L. Jorizzo, R.P. Rapini (Eds.).
251. Utsunomiya J., Gocho H., Miyanaga T., Hamaguchi E., Kashimure A. Peutz-Jeghers syndrome: its natural course and management. Johns Hopkins Med J 1975, 136:71-82.
252. Giardiello F.M., Trimbath J.D. Peutz-Jeghers syndrome and management recommendations. Clin Gastroenterol Hepatol 2006, 4:408-415.
253. Hearle N., Schumacher V., Menko F.H., Olschwang S., Boardman L.A., Gille J.J., et al. Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res 2006, 12:3209-3215.
254. Rebsdorf Pedersen I., Hartvigsen A., Fischer Hansen B., Toftgaard C., Konstantin-Hansen K., Bullow S. Management of Peutz-Jeghers syndrome. Experience with patients from the Danish Polyposis Register. Int J Colorectal Dis 1994, 9:177-179.
255. Wilson D.M., Pitts W.C., Hintz R.L., Rosenfeld R.G. Testicular tumors with Peutz-Jeghers syndrome. Cancer 1986, 57:2238-2240.
256. Hemminki A., Markie D., Tomlinson I., Avizienyte E., Roth S., Loukola A., et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998, 391:184-187.
257. Olschwang S., Markie D., Seal S., Neale K., Phillips R., Cottrell S., et al. Peutz-Jeghers disease: most, but not all, families are compatible with linkage to 19p13.3. J Med Genet 1998, 35:42-44.
258. Tsao H. Neurofibromatosis and tuberous sclerosis. Dermatology 2008, 832-838. Mosby, Spain. 2nd ed. J.L. Bolognia, J.L. Jorizzo, R.P. Rapini (Eds.).
259. Roach E.S., Gomez M.R., Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 1998, 13:624-628.
260. Flanagan N., O'Connor W.J., McCartan B., Miller S., McMenamin J., Watson R., et al. Developmental enamel defects in tuberous sclerosis: a clinical genetic marker?. J Med Genet 1997, 34:637-639.
261. Pampiglione G., Moynahan E.J. The tuberous sclerosis syndrome: clinical and EEG studies in 100 children. J Neurol Neurosurg Psychiatry 1976, 39:666-673.
262. Curatolo P., Cusmai R., Cortesi F., Chiron C., Jambaque I., Dulac O. Neuropsychiatric aspects of tuberous sclerosis. Ann NY Acad Sci 1991, 615:8-16.
263. Jozwiak S., Schwartz R.A., Janniger C.K., Bielicka-Cymerman J. Usefulness of diagnostic criteria of tuberous sclerosis complex in pediatric patients. J Child Neurol 2000, 15:652-659.
264. Roach E.S., DiMario F.J., Kandt R.S., Northrup H. Tuberous Sclerosis Consensus Conference: recommendations for diagnostic evaluation. National Tuberous Sclerosis Association. J Child Neurol 1999, 14:401-407.
265. Brook-Carter P.T., Peral B., Ward C.J., Thompson P., Hughes J., Maheshwar M.M., et al. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease-a contiguous gene syndrome. Nat Genet 1994, 8:328-332.
266. Moss J., Avila N.A., Barnes P.M., Litzenberger R.A., Bechtle J., Brooks P.G., et al. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am J Respir Crit Care Med 2001, 164:669-671.
267. O'Callaghan F.J., Clarke A.C., Joffe H., Keeton B., Martin R., Salmon A., et al. Tuberous sclerosis complex and Wolff-Parkinson-White syndrome. Arch Dis Child 1998, 78:159-162.
268. Ewalt D.H., Diamond N., Rees C., Sparagana S.P., Delgado M., Batchelor L., et al. Long-term outcome of transcatheter embolization of renal angiomyolipomas due to tuberous sclerosis complex. J Urol 2005, 174:1764-1766.